Suppr超能文献

50 岁以下患者的保留瓣膜主动脉根部替换术与带生物瓣的复合瓣叶移植物置换术。

Valve-sparing aortic root replacement versus composite valve graft with bioprosthesis in patients under age 50.

机构信息

Division of Cardiothoracic and Vascular Surgery, New York Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY.

Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Ga.

出版信息

J Thorac Cardiovasc Surg. 2024 Oct;168(4):992-1002.e1. doi: 10.1016/j.jtcvs.2023.07.016. Epub 2023 Jul 21.

Abstract

BACKGROUND

Although the unique risks of implanting a prosthetic valve after aortic valve (AV) surgery in young patients are well established, studies of aortic root replacement (ARR) are lacking. We investigated long-term outcomes after valve-sparing root replacement (VSRR) versus the use of a composite valve graft with bioprosthesis (b-CVG) in patients age <50 years.

METHODS

A total of 543 patients age <50 years underwent VSRR (n = 335) or b-CVG (n = 208) between 2004 and 2021 from 2 aortic centers, excluding those with dissection or endocarditis. Endpoints included mortality over time, reoperative aortic valve replacement (AVR), and development of greater than moderate aortic insufficiency (AI) or aortic stenosis (AS). Fine and Gray competing risk regression was used to compare the risk of reintervention. Propensity score matching (PSM) balanced patient comorbidities, and landmark analysis isolated outcomes beginning 4 years postoperatively.

RESULTS

Compared with VSRR, b-CVG was associated with lower 12-year survival (88.6% vs 92.9%; P = .036) and a higher rate of AV reintervention (37.6% vs 12.0%; P = .018). After PSM, survival was similar in the 2 arms (93.4% for b-CVG vs 93.0% for VSRR; P = .72). However, both Fine and Gray multivariable risk regression and PSM showed that b-CVG was independently associated with AV reintervention at >4 years postoperatively (Fine and Gray: subdistribution hazard ratio, 4.3 [95% confidence interval, 1.8-10.2; P = .001]; PSM: 35.7% for b-CVG versus 14.3% for VSRR; P = .024]). PSM rates of greater than moderate AI/AS at 10 years were more than 2-fold greater in the b-CVG arm compared with the VSRR arm (37.1% vs 15.9%; P = .571).

CONCLUSIONS

b-CVG in young patients is associated with early valvular degeneration, with increasing rates of reoperative AVR occurring even within 10 years. In contrast, VSRR is durable with excellent survival. In eligible young patients, every effort should be made to retain the native AV.

摘要

背景

虽然主动脉瓣(AV)手术后植入人工瓣膜的独特风险已得到充分证实,但主动脉根部置换术(ARR)的研究仍很缺乏。我们研究了<50 岁患者中保留瓣膜的根部置换术(VSRR)与使用带生物假体的复合瓣膜移植物(b-CVG)的长期结果。

方法

2004 年至 2021 年,2 个主动脉中心共对<50 岁的 543 例患者行 VSRR(n=335)或 b-CVG(n=208),排除夹层或心内膜炎患者。终点包括随时间变化的死亡率、再次主动脉瓣置换术(AVR)以及发生中度以上主动脉瓣关闭不全(AI)或主动脉瓣狭窄(AS)的情况。精细和灰色竞争风险回归用于比较再干预的风险。倾向评分匹配(PSM)平衡了患者的合并症,并在术后 4 年开始进行里程碑分析以隔离结果。

结果

与 VSRR 相比,b-CVG 术后 12 年生存率较低(88.6% vs 92.9%;P=0.036),AV 再干预率较高(37.6% vs 12.0%;P=0.018)。PSM 后,2 组的生存率相似(b-CVG 为 93.4%,VSRR 为 93.0%;P=0.72)。然而,精细和灰色多变量风险回归以及 PSM 均表明,b-CVG 独立于术后>4 年的 AV 再干预(精细和灰色:亚分布危险比,4.3[95%置信区间,1.8-10.2;P=0.001];PSM:b-CVG 为 35.7%,VSRR 为 14.3%;P=0.024])。PSM 后 10 年时,b-CVG 组的中度以上 AI/AS 发生率是 VSRR 组的 2 倍以上(37.1% vs 15.9%;P=0.571)。

结论

年轻患者使用 b-CVG 会导致早期瓣膜退行性变,即使在 10 年内,AVR 的再次发生率也会增加。相比之下,VSRR 具有良好的耐久性,生存质量极佳。在符合条件的年轻患者中,应尽力保留自身的 AV。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验